Yasir B. Al-Wakeel - Jul 6, 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role: Chief Financial Officer
Signature: /s/ Allison Frisbee, Attorney-in-Fact
Stock symbol: KRON
Transactions as of: Jul 6, 2023
Transactions value $: -$16,852
Form type: 4
Date filed: 7/7/2023, 04:06 PM
Previous filing: Jun 23, 2023
Next filing: Jun 13, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRON	Common Stock	Sale	-$16.9K	-9.62K	-2.7%	$1.75	346K	Jul 6, 2023	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
F2	The weighted average sale price for the transaction reported was $1.7523, and the range of prices were between $1.65 and $1.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.